Bardoxolone methyl oral capsule

DRUG2 trials

Sponsors

Biogen

Conditions

ADPKDAutosomal Dominant Polycystic KidneyChronic Kidney Diseases

Phase 2

A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)

CompletedNCT04702997

BiogenChronic Kidney Diseases

Start: 2021-02-09End: 2021-11-23Updated: 2025-06-03

Phase 3

A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON

TerminatedNCT03918447

BiogenADPKD, Autosomal Dominant Polycystic Kidney

Start: 2019-05-29End: 2023-08-08Updated: 2025-06-03